Skip to main content
NCBI home page
Molecular Medicine logoLink to Molecular Medicine
. 1999 Jun;5(6):361–371.

Regulation of macrophage migration inhibitory factor (MIF) expression by glucose and insulin in adipocytes in vitro.

S Sakaue 1, J Nishihira 1, J Hirokawa 1, H Yoshimura 1, T Honda 1, K Aoki 1, S Tagami 1, Y Kawakami 1
PMCID: PMC2230432  PMID: 10415161

Abstract

BACKGROUND: It has been reported that macrophage migration inhibitory factor (MIF) stimulated insulin secretion from pancreatic islet beta-cells in an autocrine manner, which suggests its pivotal role in the glucose metabolism. According to this finding, we evaluated MIF expression in cultured adipocytes and epididymal fat pads of obese and diabetic rats to investigate its role in adipose tissue. MATERIALS AND METHODS: The murine adipocyte cell line 3T3-L1 was used to examine MIF mRNA expression and production of MIF protein in response to various concentrations of glucose and insulin. Epididymal fat pads of Otsuka Long-Evans Tokushima fatty (OLETF) and Wistar fatty rats, animal models of obesity and diabetes, were subjected to Northern blot analysis to determine MIF mRNA levels. RESULTS: MIF mRNA of 3T3-L1 adipocytes was up-regulated by costimulation with glucose and insulin. Intracellular MIF content was significantly increased by stimulation, whereas its content in the culture medium was decreased. When the cells were treated with cytochalasin B, MIF secretion in the medium was increased. Pioglitazone significantly increased MIF content in the culture medium of 3T3-L1 cells. However, MIF mRNA expression of both epididymal fat pads of OLETF and Wistar fatty rats was down-regulated despite a high plasma glucose level. The plasma MIF level of Wistar fatty rats was significantly increased by treatment with pioglitazone. CONCLUSION: We show here that the intracellular glucose level is critical to determining the MIF mRNA level as well as its protein content in adipose tissue. MIF is known to play an important role in glucose metabolism as a positive regulator of insulin secretion. In this context, it is conceivable that MIF may affect the pathophysiology of obesity and diabetes.

Full text

PDF
361

Images in this article

364Fig. 1
on p.364
364Fig. 2
on p.364
365Fig. 3
on p.365
365Fig. 4
on p.365
366Fig. 5
on p.366
367Fig. 6
on p.367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacher M., Meinhardt A., Lan H. Y., Mu W., Metz C. N., Chesney J. A., Calandra T., Gemsa D., Donnelly T., Atkins R. C. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol. 1997 Jan;150(1):235–246. [PMC free article] [PubMed] [Google Scholar]
  2. Bacher M., Metz C. N., Calandra T., Mayer K., Chesney J., Lohoff M., Gemsa D., Donnelly T., Bucala R. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7849–7854. doi: 10.1073/pnas.93.15.7849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernhagen J., Bacher M., Calandra T., Metz C. N., Doty S. B., Donnelly T., Bucala R. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med. 1996 Jan 1;183(1):277–282. doi: 10.1084/jem.183.1.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bernhagen J., Calandra T., Mitchell R. A., Martin S. B., Tracey K. J., Voelter W., Manogue K. R., Cerami A., Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 1993 Oct 21;365(6448):756–759. doi: 10.1038/365756a0. [DOI] [PubMed] [Google Scholar]
  5. Bloom B. R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966 Jul 1;153(3731):80–82. doi: 10.1126/science.153.3731.80. [DOI] [PubMed] [Google Scholar]
  6. Calandra T., Bernhagen J., Metz C. N., Spiegel L. A., Bacher M., Donnelly T., Cerami A., Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995 Sep 7;377(6544):68–71. doi: 10.1038/377068a0. [DOI] [PubMed] [Google Scholar]
  7. Calandra T., Bernhagen J., Mitchell R. A., Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994 Jun 1;179(6):1895–1902. doi: 10.1084/jem.179.6.1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen L., Alam T., Johnson J. H., Hughes S., Newgard C. B., Unger R. H. Regulation of beta-cell glucose transporter gene expression. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4088–4092. doi: 10.1073/pnas.87.11.4088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966 Jul;56(1):72–77. doi: 10.1073/pnas.56.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hallakou S., Doaré L., Foufelle F., Kergoat M., Guerre-Millo M., Berthault M. F., Dugail I., Morin J., Auwerx J., Ferré P. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes. 1997 Sep;46(9):1393–1399. doi: 10.2337/diab.46.9.1393. [DOI] [PubMed] [Google Scholar]
  11. Hirokawa J., Sakaue S., Furuya Y., Ishii J., Hasegawa A., Tagami S., Kawakami Y., Sakai M., Nishi S., Nishihira J. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J Biochem. 1998 Apr;123(4):733–739. doi: 10.1093/oxfordjournals.jbchem.a021998. [DOI] [PubMed] [Google Scholar]
  12. Hirokawa J., Sakaue S., Tagami S., Kawakami Y., Sakai M., Nishi S., Nishihira J. Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha. Biochem Biophys Res Commun. 1997 Jun 9;235(1):94–98. doi: 10.1006/bbrc.1997.6745. [DOI] [PubMed] [Google Scholar]
  13. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995 May;95(5):2409–2415. doi: 10.1172/JCI117936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hotamisligil G. S., Budavari A., Murray D., Spiegelman B. M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest. 1994 Oct;94(4):1543–1549. doi: 10.1172/JCI117495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hotamisligil G. S., Murray D. L., Choy L. N., Spiegelman B. M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854–4858. doi: 10.1073/pnas.91.11.4854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hotamisligil G. S., Peraldi P., Budavari A., Ellis R., White M. F., Spiegelman B. M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996 Feb 2;271(5249):665–668. doi: 10.1126/science.271.5249.665. [DOI] [PubMed] [Google Scholar]
  17. Hotamisligil G. S., Shargill N. S., Spiegelman B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993 Jan 1;259(5091):87–91. doi: 10.1126/science.7678183. [DOI] [PubMed] [Google Scholar]
  18. Ikeda H., Shino A., Matsuo T., Iwatsuka H., Suzuoki Z. A new genetically obese-hyperglycemic rat (Wistar fatty). Diabetes. 1981 Dec;30(12):1045–1050. doi: 10.2337/diab.30.12.1045. [DOI] [PubMed] [Google Scholar]
  19. Ishida K., Mizuno A., Murakami T., Shima K. Obesity is necessary but not sufficient for the development of diabetes mellitus. Metabolism. 1996 Oct;45(10):1288–1295. doi: 10.1016/s0026-0495(96)90250-4. [DOI] [PubMed] [Google Scholar]
  20. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992 Nov;41(11):1422–1428. doi: 10.2337/diab.41.11.1422. [DOI] [PubMed] [Google Scholar]
  21. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 1995 Jun 2;270(22):12953–12956. doi: 10.1074/jbc.270.22.12953. [DOI] [PubMed] [Google Scholar]
  22. Makita H., Nishimura M., Miyamoto K., Nakano T., Tanino Y., Hirokawa J., Nishihira J., Kawakami Y. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med. 1998 Aug;158(2):573–579. doi: 10.1164/ajrccm.158.2.9707086. [DOI] [PubMed] [Google Scholar]
  23. Murase K., Odaka H., Suzuki M., Tayuki N., Ikeda H. Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats. Diabetologia. 1998 Mar;41(3):257–264. doi: 10.1007/s001250050901. [DOI] [PubMed] [Google Scholar]
  24. Nishihira J., Kuriyama T., Sakai M., Nishi S., Ohki S., Hikichi K. The structure and physicochemical properties of rat liver macrophage migration inhibitory factor. Biochim Biophys Acta. 1995 Feb 22;1247(1):159–162. doi: 10.1016/0167-4838(94)00215-3. [DOI] [PubMed] [Google Scholar]
  25. RODBELL M. METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem. 1964 Feb;239:375–380. [PubMed] [Google Scholar]
  26. Sakai M., Nishihira J., Hibiya Y., Koyama Y., Nishi S. Glutathione binding rat liver 13k protein is the homologue of the macrophage migration inhibitory factor. Biochem Mol Biol Int. 1994 Jun;33(3):439–446. [PubMed] [Google Scholar]
  27. Samad F., Yamamoto K., Loskutoff D. J. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. J Clin Invest. 1996 Jan 1;97(1):37–46. doi: 10.1172/JCI118404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sugimoto H., Suzuki M., Nakagawa A., Tanaka I., Fujinaga M., Nishihira J. Crystallization of rat liver macrophage migration inhibitory factor for MAD analysis. J Struct Biol. 1995 Nov-Dec;115(3):331–334. doi: 10.1006/jsbi.1995.1057. [DOI] [PubMed] [Google Scholar]
  29. Sugiyama Y., Shimura Y., Ikeda H. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats. Arzneimittelforschung. 1990 Apr;40(4):436–440. [PubMed] [Google Scholar]
  30. Suzuki H., Kanagawa H., Nishihira J. Evidence for the presence of macrophage migration inhibitory factor in murine reproductive organs and early embryos. Immunol Lett. 1996 Jul;51(3):141–147. doi: 10.1016/0165-2478(96)02543-6. [DOI] [PubMed] [Google Scholar]
  31. Suzuki K., Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci U S A. 1980 May;77(5):2542–2545. doi: 10.1073/pnas.77.5.2542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Szalkowski D., White-Carrington S., Berger J., Zhang B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology. 1995 Apr;136(4):1474–1481. doi: 10.1210/endo.136.4.7895657. [DOI] [PubMed] [Google Scholar]
  33. Waeber G., Calandra T., Roduit R., Haefliger J. A., Bonny C., Thompson N., Thorens B., Temler E., Meinhardt A., Bacher M. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4782–4787. doi: 10.1073/pnas.94.9.4782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994 Dec 1;372(6505):425–432. doi: 10.1038/372425a0. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES